Skip to main content
HR 1736 108th Congress House Health Blood transfusions Case management Child health Communication in medicine Community health services Congress Congressional reporting requirements Continuing education Continuum of care Economics and Public Finance Education Families Federal aid to child health services Federal aid to health facilities Genetic counseling Government Operations and Politics Health education Health insurance Higher education

Sickle Cell Treatment Act of 2003

Introduced: April 10, 2003 Introduced by: Davis, Danny K. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2003
Sponsor introductory remarks on measure. (CR H9003)
Apr 24, 2003
Referred to the Subcommittee on Health.
Apr 10, 2003
Referred to the House Committee on Energy and Commerce.
Apr 10, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Sickle Cell Treatment Act of 2003 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to include primary and secondary preventative medical strategies, treatment, and services, including genetic counseling and testing, for individuals who have Sickle Cell Disease as medical assistance under the Medicaid program.

Directs the Administrator of the Health Resources and Services Administration to conduct a demonstration program for the development and establishment of systemic mechanisms, including a National Coordinating Center, to improve the prevention and treatment of Sickle Cell Disease.

What's happening now September 30, 2003

Sponsor introductory remarks on measure. (CR H9003)

 Related & companion bills 1
  • S 874 Identical bill Sickle Cell Treatment Act of 2003
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 5
D
DeLauro, Rosa L.
Connecticut · Feb 24, 2004
 D
Schakowsky, Janice D.
Illinois · Jun 10, 2003
 D
Norton, Eleanor Holmes
District of Columbia · May 21, 2003
 D
Clyburn, James E.
South Carolina · May 20, 2003
 D
Scott, Robert C. "Bobby"
Virginia · May 20, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1736: Sickle Cell Treatment Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-HR-1736/
MLA
"H.R. 1736: Sickle Cell Treatment Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-1736/.
Bluebook (legal)
H.R. 1736, 108th Cong. (2026), https://openamerica.io/bill/108-HR-1736/.
Markdown link
[H.R. 1736: Sickle Cell Treatment Act of 2003](https://openamerica.io/bill/108-HR-1736/)
Report a problem